Literature DB >> 22378039

Multistep activation of the Helicobacter pylori effector CagA.

Anne Müller1.   

Abstract

Chronic infection with the Gram-negative bacterium Helicobacter pylori is a major risk factor for the development of gastric cancer. Accumulating evidence indicates that the H. pylori virulence determinant cytotoxin-associated gene A (CagA) has a key oncogenic role in the process. Certain biological activities of CagA require its tyrosine phosphorylation by host cell kinases. In this issue of the JCI, Mueller and colleagues report their detailed kinetic and functional analysis of CagA phosphorylation, which indicates that c-Src and c-Abl kinases sequentially phosphorylate CagA. Interestingly, the two phosphorylation events need not occur on the same CagA molecule but are both required for the biological effects of CagA. The results provide a clinically relevant example of how a successful bacterial pathogen has evolved to exploit the tightly coordinated, sequential activity of host cell kinases for virulence factor activation and induction of pathology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22378039      PMCID: PMC3314475          DOI: 10.1172/JCI61578

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion.

Authors:  S Odenbreit; J Püls; B Sedlmaier; E Gerland; W Fischer; R Haas
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

2.  SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein.

Authors:  Hideaki Higashi; Ryouhei Tsutsumi; Syuichi Muto; Toshiro Sugiyama; Takeshi Azuma; Masahiro Asaka; Masanori Hatakeyama
Journal:  Science       Date:  2001-12-13       Impact factor: 47.728

3.  Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.

Authors:  J Parsonnet; G D Friedman; N Orentreich; H Vogelman
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

4.  cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors.

Authors:  S Censini; C Lange; Z Xiang; J E Crabtree; P Ghiara; M Borodovsky; R Rappuoli; A Covacci
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo.

Authors:  Matthias Selbach; Stefan Moese; Christof R Hauck; Thomas F Meyer; Steffen Backert
Journal:  J Biol Chem       Date:  2002-01-11       Impact factor: 5.157

6.  Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA.

Authors:  Manuel R Amieva; Roger Vogelmann; Antonello Covacci; Lucy S Tompkins; W James Nelson; Stanley Falkow
Journal:  Science       Date:  2003-05-30       Impact factor: 47.728

7.  Meta-analysis of the relationship between cagA seropositivity and gastric cancer.

Authors:  Jia Qing Huang; Ge Fan Zheng; Katica Sumanac; E Jan Irvine; Richard H Hunt
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

8.  Attenuation of Helicobacter pylori CagA x SHP-2 signaling by interaction between CagA and C-terminal Src kinase.

Authors:  Ryouhei Tsutsumi; Hideaki Higashi; Megumi Higuchi; Masato Okada; Masanori Hatakeyama
Journal:  J Biol Chem       Date:  2002-11-21       Impact factor: 5.157

9.  Helicobacter pylori infection and the risk of gastric carcinoma.

Authors:  J Parsonnet; G D Friedman; D P Vandersteen; Y Chang; J H Vogelman; N Orentreich; R K Sibley
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

10.  Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites.

Authors:  Hideaki Higashi; Ryouhei Tsutsumi; Akiko Fujita; Shiho Yamazaki; Masahiro Asaka; Takeshi Azuma; Masanori Hatakeyama
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

View more
  12 in total

Review 1.  Helicobacter pylori in gastric malignancies.

Authors:  Abhishek Bhandari; Sheila E Crowe
Journal:  Curr Gastroenterol Rep       Date:  2012-12

Review 2.  Multifunctional Abl kinases in health and disease.

Authors:  Aaditya Khatri; Jun Wang; Ann Marie Pendergast
Journal:  J Cell Sci       Date:  2016-01-01       Impact factor: 5.285

Review 3.  Bacterial pathogens commandeer Rab GTPases to establish intracellular niches.

Authors:  Mary-Pat Stein; Matthias P Müller; Angela Wandinger-Ness
Journal:  Traffic       Date:  2012-09-13       Impact factor: 6.215

Review 4.  Gastric cancer-molecular and clinical dimensions.

Authors:  Roopma Wadhwa; Shumei Song; Ju-Seog Lee; Yixin Yao; Qingyi Wei; Jaffer A Ajani
Journal:  Nat Rev Clin Oncol       Date:  2013-09-24       Impact factor: 66.675

5.  Dietary factors modulate Helicobacter-associated gastric cancer in rodent models.

Authors:  James G Fox; Timothy C Wang
Journal:  Toxicol Pathol       Date:  2013-12-03       Impact factor: 1.902

6.  A specific A/T polymorphism in Western tyrosine phosphorylation B-motifs regulates Helicobacter pylori CagA epithelial cell interactions.

Authors:  Xue-Song Zhang; Nicole Tegtmeyer; Leah Traube; Shawn Jindal; Guillermo Perez-Perez; Heinrich Sticht; Steffen Backert; Martin J Blaser
Journal:  PLoS Pathog       Date:  2015-02-03       Impact factor: 6.823

7.  Cytotoxic and pathogenic properties of Klebsiella oxytoca isolated from laboratory animals.

Authors:  Alison Darby; Kvin Lertpiriyapong; Ujjal Sarkar; Uthpala Seneviratne; Danny S Park; Eric R Gamazon; Chara Batchelder; Cheryl Cheung; Ellen M Buckley; Nancy S Taylor; Zeli Shen; Steven R Tannenbaum; John S Wishnok; James G Fox
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

8.  In depth analysis of the Helicobacter pylori cag pathogenicity island transcriptional responses.

Authors:  Andrea Vannini; Davide Roncarati; Marco Spinsanti; Vincenzo Scarlato; Alberto Danielli
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

9.  Dramatic increase in SHP2 binding activity of Helicobacter pylori Western CagA by EPIYA-C duplication: its implications in gastric carcinogenesis.

Authors:  Lisa Nagase; Takeru Hayashi; Toshiya Senda; Masanori Hatakeyama
Journal:  Sci Rep       Date:  2015-10-28       Impact factor: 4.379

10.  Helicobacter pylori vacA genotype is a predominant determinant of immune response to Helicobacter pylori CagA.

Authors:  Alexander Link; Cosima Langner; Wiebke Schirrmeister; Wiebke Habendorf; Jochen Weigt; Marino Venerito; Ina Tammer; Dirk Schlüter; Philipp Schlaermann; Thomas F Meyer; Thomas Wex; Peter Malfertheiner
Journal:  World J Gastroenterol       Date:  2017-07-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.